SC slams Centre, drug regulator over expired Covid-era approvals for antifungal drug
Hindustan Times

The top court expressed dismay over the delay in initiating regulatory action against companies accused of continuing to rely on temporary pandemic-era permissions
Summary from Hindustan Times
Read the full story on Hindustan TimesFollow










